Renascience Inc.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
Renascience Inc.
Renascience Inc. (株式会社レナサイエンス, 4889), Pharmaceutical. A board of 6 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YGXR, filed 2026-06-23. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2022-03-31 | 0.1 | −0.3 | 2.4 | −22.33 | — | 4 |
| 2023-03-31 | 0.1 | −0.3 | 2.3 | −26.42 | — | 3 |
| 2024-03-31 | 0.2 | −0.3 | 2.1 | −20.32 | — | 4 |
| 2025-03-31 | 0.1 | 0.1 | 1.9 | 8.92 | — | 3 |
| 2026-03-31 | 0.1 | −0.3 | 3.5 | −23.39 | — | 3 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown